Old Web
English
Sign In
Acemap
>
authorDetail
>
Guofang Sun
Guofang Sun
Hoffmann-La Roche
Medicine
Oncology
Internal medicine
Trastuzumab
Breast cancer
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Trastuzumab emtansine (T-DM1) versus trastuzumab in Chinese patients with residual invasive disease after neoadjuvant chemotherapy and HER2-targeted therapy for HER2-positive breast cancer in the phase 3 KATHERINE study.
2021
Breast Cancer Research and Treatment
Chiun-Sheng Huang
Youngsen Yang
Ava Kwong
Shin-Cheh Chen
Ling-Ming Tseng
Mei Ching Liu
Kunwei Shen
Shusen Wang
Ting Ying Ng
Yi Feng
Guofang Sun
Iris Renfei Yan
Zhimin Shao
Show All
Source
Cite
Save
Citations (0)
A phase I study of pharmacokinetics of trastuzumab emtansine in Chinese patients with locally advanced inoperable or metastatic human epidermal growth factor receptor 2-positive breast cancer who have received prior trastuzumab-based therapy.
2020
Medicine
Dongmei Ji
Weina Shen
Jian Zhang
Junning Cao
Wenhua Li
Lisa H. Lam
Fan Wu
Bei Wang
Zao Li
Guofang Sun
Xichun Hu
Shang-Chiung Chen
Show All
Source
Cite
Save
Citations (0)
Real-world clinical characteristics and treatment of advanced non-small cell lung cancer (NSCLC) patients in China.
2018
Journal of Clinical Oncology
Yuankai Shi
Xin Zhang
Gang Wu
Jianping Xu
Yong He
Dong Wang
Cheng Huang
Mingwei Chen
Ping Yu
Yan Yu
Wei Li
Qi Li
Xiao-hua Hu
Guofang Sun
Yulin Li
Lilian Bu
Show All
Source
Cite
Save
Citations (0)
1